N@N

Market Maker Surveillance Report. GLUU, ZAAP, RMTR, GNI, GCFB, PDLI, Losing Stocks With Lowest Price Friction For Monday, Janu

^{Published on 2011-01-10 17:51:19 - WOPRAI}
 

January 10, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 2593 companies with "abnormal" market making, 2666 companies with positive Friction Factors and 2512 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. GLU MOBILE INC (NASDAQ:GLUU), ZAP (OTCBB:ZAAP), RAMTRON INTERNATIONAL CORP (NASDAQ:RMTR), GREAT NORTHERN IRON ORE PPTY (NYSE:GNI), GRANITE CITY FOOD & BREWERY (NASDAQ:GCFB), PDL BIOPHARMA INC (NASDAQ:PDLI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     GLUU       $-0.310      -11.83%      349,068         39.24%       538,733         60.56%       -189,665        -6,118  
     ZAAP       $-0.494      -27.75%      765,291         40.70%       1,103,390       58.69%       -338,099        -6,844  
     RMTR       $-0.440      -12.09%      109,300         33.28%       218,043         66.39%       -108,743        -2,471  
     GNI        $-24.620     -18.48%      57,811          39.72%       76,361          52.47%       -18,550         -8      
     GCFB       $-0.690      -14.41%      42,530          42.37%       56,454          56.24%       -13,924         -202    
     PDLI       $-0.760      -12.32%      3,222,078       49.27%       3,278,142       50.12%       -56,064         -738    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PDLI with a dollar loss Monday of $-0.76000 and a Friction Factor of -738 shares. That means that it only took 738 more shares of selling than buying to move PDLI lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

GLU MOBILE INC (NASDAQ:GLUU) - Glu Mobile Inc. engages in the design, marketing, and sale of mobile games worldwide. The companys games based on licensed intellectual property include Call of Duty, Deer Hunter, Diner Dash, Guitar Hero 5, Family Feud, Family Guy, The Price Is Right, Transformers, Wedding Dash, Who Wants to Be a Millionaire?, World Series of Poker, and Zuma; and games based on its own intellectual property comprise Beat It!, Bonsai Blast, Brain Genius, Glyder, Stranded, and Super K.O. Boxing. It designs a portfolio of games for the wireless subscriber population, as well as for the users of smartphones. The company also develops games for social networking Websites. It markets and sells its games primarily through wireless carriers. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 2005. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Mateo, California.

ZAP (OTCBB:ZAAP) - ZAP engages in the development, acquisition, and commercialization of electric vehicles and electric vehicle power systems in the United States. It offers on-campus trucks and vans to various government organizations including FAA, US military, and state government patrol vehicles; and sport utility vehicles for taxi fleet market. The company markets various forms of transportation, including alternative energy and fuel efficient automobiles, motorcycles, bicycles, scooters, personal watercraft, hovercraft, neighborhood electric vehicles, and commercial vehicles. It also operates a retail car lot for sale of conventional and electric vehicles, as well as sells its products through the Internet. The company was formerly known as ZAPWORLD.COM and changed its name to ZAP in 2001. ZAP was founded in 1994 and is headquartered in Santa Rosa, California.

RAMTRON INTERNATIONAL CORP (NASDAQ:RMTR) - Ramtron International Corporation, a fabless semiconductor company, designs, develops, and markets specialized semiconductor memory, microcontroller, and integrated semiconductor solutions. It integrates ferroelectric materials into semiconductor products, which enable the development of ferroelectric random access memory (F-RAM) products that merge the multiple memory technologies into a single device. The companys F-RAM product line includes various interfaces and densities, such as industry-standard serial and parallel interfaces; industry standard package types; and 4-kilobit, 16-kilobit, 64-kilobit, 256-kilobit, 1-megabit, 2-megabit, and 4-megabit densities. Its serial F-RAM devices allow more frequent data transfers over the serial bus to the processor; parallel F-RAM products are drop-in replacements for battery-backed SRAM products; and integrated F-RAM products, also known as processor companions, are single-chip solutions that replace a number of individual system components to reduce cost and board space. The company serves various customers for a range of applications in the metering, computing and information systems, automotive, communications, consumer and industrial, scientific, and medical markets. Ramtron International sells its products through direct sales force, manufacturers representatives, and distributors in the Americas, Europe, the Asia Pacific, and Japan. The company was founded in 1984 and is headquartered in Colorado Springs, Colorado.

GREAT NORTHERN IRON ORE PPTY (NYSE:GNI) - Great Northern Iron Ore Properties owns and leases mineral and nonmineral lands on the Mesabi Iron Range in northeastern Minnesota. As of December 31, 2009, it owned mineral interests in 12,033 acres on the Mesabi Iron Range Formation, including approximately 7,443 acres that are wholly owned. The company was founded in 1906 and is based in Saint Paul, Minnesota.

GRANITE CITY FOOD & BREWERY (NASDAQ:GCFB) - Granite City Food & Brewery Ltd. engages in the development and operation of a chain of casual dining restaurants in the United States. The companys restaurants also feature on-premises breweries that offer five styles of beer, as well as specialty or seasonal beers. As of March 18, 2010, it operated 26 restaurants in 11 Midwestern states under the name of Granite City Food & Brewery. The company was founded in 1997 and is headquartered in Minneapolis, Minnesota.

PDL BIOPHARMA INC (NASDAQ:PDLI) - PDL BioPharma Inc., formerly Protein Design Labs, Inc., is a biopharmaceutical company focused on discovering, developing and commercializing therapies for severe or life threatening illnesses. The Company markets and sells products in the acute care hospital setting in the United States and Canada, and receives royalties through licensing agreements with a number of biotechnology and pharmaceutical companies based on its antibody humanization technology platform. The Company's product development pipeline includes six investigational compounds in Phase II or Phase III clinical development for hepatorenal syndrome, inflammation and autoimmune diseases, cardiovascular disorders and cancer. On March 23, 2005, the Company completed the acquisition of all of the outstanding stock of ESP Pharma Holding Company, Inc. (ESP Pharma), a privately held hospital-focused company. It also acquired from Centocor, Inc. (Centocor) the right to manufacture, develop, market and distribute Retavase in the United States and Canada during the year ended December 31, 2005.

Marketed Products

The Company's portfolio of actively marketed products consists of three biopharmaceutical products. Cardene IV is a branded, United States-approved dihydropyridine class calcium channel blocker delivered intravenously that is indicated for short-term treatment of hypertension when oral therapy is not feasible or desirable. Retavase is indicated for use in the management of heart attacks (acute myocardial infarction (AMI)) in adults for the improvement of ventricular function following AMI, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI. The Company re-launched Retavase in April 2005, after acquiring it in March 2005.

IV Busulfex, an IV formulation of busulfan, is a chemotherapeutic agent used as part of a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia. IV Busulfex provides anti-tumor effect to eradicate residual malignancy, ablation of the bone marrow to make space for the new source of stem cells and to provide immunosuppression to prevent graft rejection. IV Busulfex was launched in Europe by Pierre Fabre Medicament S.A. (Pierre Fabre) and in several Asian countries by Kirin Brewery Company, Limited (Kirin). Both Pierre Fabre and Kirin are the Company's distributors in their territories.

Products in Clinical Development

PDL BioPharma Inc. is engaged in the discovery and development of protein-based therapeutic products, with the majority of its emphasis based upon deriving humanized antibody product candidates employing its platform. The Company has six product candidates in clinical development for various disease indications. Four of these are antibodies and are in clinical development with a near-term emphasis on autoimmune and inflammatory diseases and cancer, specifically inflammatory bowel disease, asthma, multiple sclerosis (MS) and solid tumors. The remaining two product candidates, ularitide and terlipressin, were added to the portfolio through the Company's acquisition of ESP Pharma.

Terlipressin is a synthetic, 12-amino acid peptide (1-triglycyl-8-lysine-vasopressin) derived from the natural hormone lysine-vasopressin. Due to its constrictive activity on vascular and extra-vascular smooth muscle cells (V-1 agonist), it reduces blood flow in the splanchnic area, and thereby lowers portal blood pressure. Terlipressin is in Phase III clinical development for the treatment of type 1 hepatorenal syndrome.

Under an agreement with Orphan Therapeutics, PDL BioPharma Inc. holds marketing, sales and distribution rights for terlipressin in the United States and Canada. Orphan Therapeutics holds the investigational new drug (IND) application for terlipressin and is conducting the Phase III clinical trial in the United States and Europe. The ongoing clinical study, conducted by Orphan Therapeutics, is a double-blind, placebo-controlled Phase III trial of terlipressin in patients with type 1 hepatorenal

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net